Pill
Latest Pfizer Inc. Patents:
- CDCP1 antibodies and antibody drug conjugates
- Pyrrolo[2,3-d]pyrimidinyl, Pyrrolo[2,3-b]pyrazinyl and Pyrrolo[2,3-d]pyridinyl Acryla-mides
- CRYSTAL-FREE HIGH-CONCENTRATION TESTOSTERONE CYPIONATE FORMULATIONS
- Dosing Regimen of Avelumab for the Treatment of Cancer
- 3-indol substituted derivatives, pharmaceutical compositions and methods for use
Description
The shading in the figures are for illustrative purposes only and form no part of the claimed design.
Claims
The ornamental design for a pill, as shown and described.
Referenced Cited
U.S. Patent Documents
| D359554 | June 20, 1995 | Dansereau |
| D425614 | May 23, 2000 | Chen |
| D430285 | August 29, 2000 | Chen |
| D431076 | September 19, 2000 | Chen |
| D434846 | December 5, 2000 | Chen |
| D500849 | January 11, 2005 | Rinker |
| D506544 | June 21, 2005 | Rinker |
| D515202 | February 14, 2006 | Chen |
| D534646 | January 2, 2007 | Chang |
| D631537 | January 25, 2011 | Sadler |
| D773641 | December 6, 2016 | Sadler |
| D835257 | December 4, 2018 | Parikh |
| D858741 | September 3, 2019 | Parikh |
| D907760 | January 12, 2021 | Hassan |
Patent History
Patent number: D1017017
Type: Grant
Filed: Dec 20, 2021
Date of Patent: Mar 5, 2024
Assignee: Pfizer Inc. (New York, NY)
Inventors: Patrick David Daugherity (Niantic, CT), Weili Yu (Pawcatuck, CT), Daniel R. Arenson (Lake Oswego, OR)
Primary Examiner: Charles D Hanson
Application Number: 29/820,186
Type: Grant
Filed: Dec 20, 2021
Date of Patent: Mar 5, 2024
Assignee: Pfizer Inc. (New York, NY)
Inventors: Patrick David Daugherity (Niantic, CT), Weili Yu (Pawcatuck, CT), Daniel R. Arenson (Lake Oswego, OR)
Primary Examiner: Charles D Hanson
Application Number: 29/820,186
Classifications
Current U.S. Class:
Tablet Or Caplet (1) (D24/101)